Skip to main content
. 2017 Feb 18;34(4):407–415. doi: 10.1093/fampra/cmw136

Table 1.

Throat swabs taken by clinician at baseline study visit: methods of microbe identification and prevalence at baseline study visit

Microbe Method of identification Prevalence
n/N (%)
Bacteria
Staphylocococcus aureus Culture 725/2170 (33.4%)
Haemophilus influenzae Culture 513/2170 (23.6%)
Streptococcus pneumoniae Culture 322/2170 (14.8%)
 Group A beta haemolytic Streptococcus Culture 183/2170 (8.4%)
Mycoplasma pneumoniae qPCR 72/2132 (3.4%)
 Group G beta haemolytic Streptococcus Culture 37/2170 (1.7%)
Bordetella pertussis qPCR 27/2132 (1.3%)
 Group C beta haemolytic Streptococcus Culture 20/2170 (0.9%)
Chlamydophilia pneumoniae qPCR 8/2132 (0.4%)
Bordetella parapertussis qPCR 6/2131 (0.3%)
Moraxella catarrhalis Culture 5/2170 (0.2%)
 Group F beta haemolytic Streptococcus Culture 0/2170 (0.0%)
Viruses
 Rhinovirus qPCR 272/2152 (12.6%)
 Enterovirus qPCR 139/2132 (6.5%)
 Respiratory syncytial viruses qPCR 129/2181 (5.9%)
 Influenza A qPCR 96/2181 (4.4%)
 Coronavirus qPCR 85/2132 (4.0%)
 Parainfluenzavirus type 3 qPCR 61/2181 (2.8%)
 Metapneumoviruses qPCR 57/2181 (2.6%)
 Bocavirus qPCR 48/2132 (2.3%)
 Influenza B qPCR 48/2181 (2.2%)
 Adenovirus qPCR 41/2179 (1.9%)
 Parainfluenzavirus type 1 qPCR 35/2181 (1.6%)
 Parainfluenzavirus type 4 qPCR 24/2132 (1.1%)
 Parechovirus qPCR 9/2132 (0.4%)
 Parainfluenzavirus type 2 qPCR 5/2181 (0.2%)

qPCR = pathogen identified by quantitative PCR.